Aura Biosciences, Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Aura Biosciences, Inc.
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
/ 
Frequently asked questions
To buy Aura Biosciences, Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Aura Biosciences, Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Aura Biosciences, Inc. is AURA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Aura Biosciences, Inc. has its primary listing on NASDAQ. You can trade Aura Biosciences, Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Aura Biosciences, Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Aura Biosciences, Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Aura Biosciences, Inc..